Parkinson's disease (PD) is the second most predominant neurodegenerative disease
worldwide. It is recognized clinically by severe complications in motor function caused by …

Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder
worldwide. Clinically, it is characterized by severe motor complications caused by a …

Parkinson's disease (PD) is a progressively debilitating neurodegenerative condition that
leads to motor and cognitive dysfunction. At present, clinical treatment can only improve …

Short-term symptomatic treatment and dose-dependent side effects of pharmacological
treatment for neurodegenerative diseases have forced the medical community to seek an …

Neurologic complications are commonly regarded as irreversible impairments that stem from
limited potential of regeneration of the central nervous system (CNS). On the other side, the …

Microglia-mediated inflammatory responses have been shown to play a crucial role in
Parkinson's disease. In addition, exosomes derived from mesenchymal stem cells have …

Mesenchymal stem cell (MSC)-derived secretome demonstrated therapeutic effects like
those reported after MSCs transplantation. MSC-derived secretome may avoid various side …

Neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease,
Huntington's disease and amyotrophic lateral sclerosis, are a group of incurable …

Neurodegenerative disease refers to any pathological condition in which there is a
progressive decline in neuronal function resulting from brain atrophy. Despite the immense …

Parkinson's disease (PD) is characterized by a selective loss of dopamine (DA) neurons in
the human midbrain causing motor dysfunctions. The exact mechanism behind …